Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for ...
Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global ...
Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that the ...
Ramanujan’s elegant formulas for calculating pi, developed more than a century ago, have unexpectedly resurfaced at the heart of modern physics. Researchers at IISc discovered that the same ...